GLPwatch

GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake.

Endocrinology · 2012

Last updated 2026-05-28

Researchers found that brain cells producing GLP-1 in the nucleus of the solitary tract send direct signals to two reward-related brain areas—the ventral tegmental area (VTA) and the nucleus accumbens (NAc). Activating GLP-1 receptors in these areas reduced food intake, particularly of highly palatable foods, and lowered body weight, while blocking these receptors increased food intake.

AI summary of the abstract below.

JournalEndocrinology, 2012
Citations408
Relative citation ratio13.86
NIH percentile99
Molecules
Conditions studied Obesity

Abstract

Central glucagon-like-peptide-1 (GLP-1) receptor activation reduces food intake; however, brain nuclei and mechanism(s) mediating this effect remain poorly understood. Although central nervous system GLP-1 is produced almost exclusively in the nucleus of the solitary tract in the hindbrain, GLP-1 receptors (GLP-1R) are expressed throughout the brain, including nuclei in the mesolimbic reward system (MRS), e.g. the ventral tegmental area (VTA) and the nucleus accumbens (NAc). Here, we examine the MRS as a potential site of action for GLP-1-mediated control of food intake and body weight. Double immunohistochemistry for Fluorogold (monosynaptic retrograde tracer) and GLP-1 neuron immunoreactivity indicated that GLP-1-producing nucleus tractus solitarius neurons project directly to the VTA, the NAc core, and the NAc shell. Pharmacological data showed that GLP-1R activation in the VTA, NAc core, and NAc shell decreased food intake, especially of highly-palatable foods, and body weight. Moreover, blockade of endogenous GLP-1R signaling in the VTA and NAc core resulted in a significant increase in food intake, establishing a physiological relevance for GLP-1 signaling in the MRS. Current data highlight these nuclei within the MRS as novel sites for GLP-1R-mediated control of food intake and body weight.

Verbatim abstract via PubMed 22128031 ↗